Finance

Lists
Q2 2027 earnings • in 1 day
See details
4553:TYO
Towa Pharmaceutical Co Ltd
JP¥3,375.00
+1.96%
(+65.00) 1D
ኖቬም 9, 3:30:00 ከሰዓት ጂ ኤም ቲ+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4553...
Open
JP¥3,380
High
JP¥3,455
Low
JP¥3,350
Mkt. cap
173.87 ቢ
Avg. vol.
122.14 ሺ
Volume
136.10 ሺ
Dividend
2.37%
Quarterly dividend
JP¥20
Ex-dividend date
29 ሴፕቴ 2026
P/E ratio
20.09
52-wk high
JP¥4,490
52-wk low
JP¥2,764
EPS
JP¥168
Shares outstanding
16.40 ሚ
No. of employees
5 ሺ
Open
JP¥3,380
High
JP¥3,455
Low
JP¥3,350
Mkt. cap
173.87 ቢ
Avg. vol.
122.14 ሺ
Volume
136.10 ሺ
Dividend
2.37%
Quarterly dividend
JP¥20
Ex-dividend date
29 ሴፕቴ 2026
P/E ratio
20.09
52-wk high
JP¥4,490
52-wk low
JP¥2,764
EPS
JP¥168
Shares outstanding
16.40 ሚ
No. of employees
5 ሺ
News stories
From web sources and news partners
Central Oregon Daily
Central Oregon Daily
·
ከ29 ደቂቃዎች በፊት
Wall St jumps back as oil slide eases inflation worries; Nvidia slumps
Bloomberg.com
Bloomberg.com
·
ከ30 ደቂቃዎች በፊት
Violent Tech Rout Will Avoid a 20% Drawdown: Markets Pulse
Seeking Alpha
Seeking Alpha
·
ከ26 ደቂቃዎች በፊት
What Happened To The November Time Target? (SP500)
About Towa Pharmaceutical Co Ltd
CEO-
Employees4.92 ሺ
Founded1951
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Next call in 34:05:46
ረቡዕ፣ ኖቬም 11, 8:00 ጥዋት
Fiscal period
Q2 2027
- / -
Revenue / Est. (JPY)
- / 70.90 ቢ
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
ሴፕቴ 2025
ዲሴም 2025
ማርች 2026
ጁን 2026
Revenue
65.33 ቢ
73.59 ቢ
69.64 ቢ
71.38 ቢ
Cost of goods sold
41.80 ቢ
45.67 ቢ
45.66 ቢ
45.28 ቢ
Cost of revenue
41.80 ቢ
45.67 ቢ
45.66 ቢ
45.28 ቢ
Research and development expenses
-
-
17.94 ቢ
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18.29 ቢ
18.87 ቢ
2.42 ቢ
19.58 ቢ
Operating expense
18.29 ቢ
18.87 ቢ
20.37 ቢ
19.58 ቢ
Total operating expenses
60.09 ቢ
64.54 ቢ
66.03 ቢ
64.86 ቢ
Operating income
5.24 ቢ
9.05 ቢ
3.61 ቢ
6.52 ቢ
Other non operating income
1.50 ቢ
3.31 ቢ
-4.49 ቢ
1.83 ቢ
EBT including unusual items
8.00 ቢ
12.00 ቢ
-10.79 ቢ
7.94 ቢ
EBT excluding unusual items
6.47 ቢ
12.01 ቢ
-1.29 ቢ
8.14 ቢ
Income tax expense
2.29 ቢ
3.13 ቢ
1.05 ቢ
2.41 ቢ
Effective tax rate
28.69%
26.07%
-9.70%
30.37%
Other operating expenses
-
-
-
-
Net income
5.70 ቢ
8.87 ቢ
-11.83 ቢ
5.53 ቢ
Net profit margin
8.73%
12.05%
-16.99%
7.75%
Earnings per share
-
-
-
-
Interest and investment income
93.00 ሚ
76.00 ሚ
89.00 ሚ
75.00 ሚ
Interest expense
-609.00 ሚ
-532.00 ሚ
-580.00 ሚ
-628.00 ሚ
Net interest expenses
-516.00 ሚ
-456.00 ሚ
-491.00 ሚ
-553.00 ሚ
Depreciation and amortization charges
-
-
-
-
EBITDA
10.89 ቢ
14.93 ቢ
9.66 ቢ
11.58 ቢ
Gain or loss from assets sale
32.00 ሚ
14.00 ሚ
14.80 ቢ
-2.00 ሚ
Upcoming events
AI content may include mistakes. Learn more
Google መተግበሪያዎች